Cronos (CRON) Other Non-Current Liabilities (2020 - 2026)
Cronos' (CRON) quarterly Other Non-Current Liabilities came in at $749000.0 in Q1 2026, up 22.59% year-on-year from $611000.0 in Q1 2025, and up 2.18% quarter-over-quarter from $733000.0 in Q4 2025.
Cronos (CRON) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Cronos' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $749000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 22.59% year-over-year to $749000.0 in Q1 2026; TTM through Mar 2026 was $749000.0, a 22.59% increase from a year earlier, with the FY2025 full-year figure at $733000.0, down 31.69% from the prior year.
- Other Non-Current Liabilities climbed to $749000.0 in Q1 2026 per CRON's latest filing, from $733000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $4.1 million in Q1 2022 and bottomed at $574000.0 in Q2 2022.
- The 5-year median for Other Non-Current Liabilities is $1.0 million (2023), against an average of $1.1 million.
- Across the five-year window, Other Non-Current Liabilities surged 78.22% in 2023 and slumped 43.85% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $574000.0 in 2022, then jumped by 74.74% to $1.0 million in 2023, then grew by 6.98% to $1.1 million in 2024, then tumbled by 31.69% to $733000.0 in 2025, then increased by 2.18% to $749000.0 in 2026.
- Per Business Quant, the three latest CRON Other Non-Current Liabilities figures stand at $749000.0 (Q1 2026), $733000.0 (Q4 2025), and $698000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 749,000.00 |
| Dec 31, 2025 | 733,000.00 |
| Sep 30, 2025 | 698,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 611,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.02 Mn |
| Jun 30, 2022 | 574,000.00 |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 14.38 Mn |
| Sep 30, 2021 | 34.53 Mn |
| Sep 30, 2020 | 102.66 Mn |
| Jun 30, 2020 | 205.71 Mn |